IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis

Experimental and Molecular Pathology

Volumn 92, Issue 3, 2012, Pages 327-333

  Liu, Wei ^a   Dienz, Oliver ^b   Roberts, Brian ^b   Moussawi, Mohamad ^b   Rincon, Mercedes ^b   Huber, Sally A ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Autoimmunity; CD8 T cells; Coxsackievirus B3; IL 21R; Myocarditis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CYTOKINE RESPONSE; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS MYOCARDITIS; VIRUS PATHOGENESIS; VIRUS STRAIN;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FLOW CYTOMETRY; HOST-PATHOGEN INTERACTIONS; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDITIS; RECEPTORS, INTERLEUKIN-21; SPLEEN;

ANIMALIA; COXSACKIEVIRUS; MUS;

EID: 84859801143     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.03.009     Document Type: Article

References (63)

1. Badorff C., Lee G.H., Lamphear B.J., Martone M.E., Campbell K.P., Rhoads R.E., Knowlton K.U. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nature Medicine 1999, 5:320-326.
2. Barker B.R., Parvani J.G., Meyer D., Hey A.S., Skak K., Letvin N.L. IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. Journal of Immunology 2007, 179:3596-3603.
3. Barker B.R., Gladstone M.N., Gillard G.O., Panas M.W., Letvin N.L. Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responses. European Journal of Immunology 2010, 40:3085-3096.
4. Borca M.V., Fernandez F.M., Sadir A.M., Braun M., Schudel A.A. Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology 1986, 59:261-267.
5. Bowles N.E., Ni J., Marcus F., Towbin J.A. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology 2002, 39:892-895.
6. Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., Hare J., Bricker J.T., Bowles K.R., Towbin J.A. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. Journal of the American College of Cardiology 2003, 42:466-472.
7. Bryant V., Ma C., Avery D., Liu Y., Good K., Corcoran L., de Waal Malefyt R., Tangye S. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. Journal of Immunology 2007, 179:8180-8190.
8. Chevalier M.F., Julg B., Pyo A., Flanders M., Ranasinghe S., Soghoian D.Z., Kwon D.S., Rychert J., Lian J., Muller M.I., Cutler S., McAndrew E., Jessen H., Pereyra F., Rosenberg E.S., Altfeld M., Walker B.D., Streeck H. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. Journal of Virology 2011, 85:733-741.
9. Chtanova T., Tangye S., Newton R., Frank N., Hodge M.R., Rolph M.S., Mackay C.R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. Journal of Immunology 2004, 173:68-78.
10. Coquet J.M., Kyparissoudis K., Pellicci D.G., Besra G., Berzins S.P., Smyth M.J., Godfrey D.I. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. Journal of Immunology 2007, 178:2827-2834.
11. Coquet J.M., Chakravarti S., Smyth M.J., Godfrey D.I. Cutting edge: IL-21 is not essential for TH17 differentiation or experimental autoimmune encephalomyelitis. Journal of Immunology 2008, 180:7097-7101.
12. Cui W., Liu Y., Weinstein J.S., Craft J., Kaech S.M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8(+) T cells. Immunity 2011, 35:792-805.
13. de Totero D., Meazza R., Capaia M., Fabbi M., Azzarone B., Balleari E., Gobbi M., Cutrona G., Ferrarini M., Ferrini S. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood 2008, 111:517-524.
14. Elsaesser H., Sauer K., Brooks D.G. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
15. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., Rose N.R. From infection to autoimmunity. Journal of Autoimmunity 2001, 16:175-186.
16. Fairweather D., Frisancho-Kiss S., Rose N.R. Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Reviews in Medical Virology 2005, 15:17-27.
17. Fazilleau N., Mark L., McHeyzer-Williams L.J., McHeyzer-Williams M.G. Follicular helper T cells: lineage and location. Immunity 2009, 30:324-335.
18. Frederiksen K.S., Lundsgaard D., Freeman J.A., Hughes S.D., Holm T.L., Skrumsager B.K., Petri A., Hansen L.T., McArthur G.A., Davis I.D., Skak K. IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunology, Immunotherapy 2008, 57:1439-1449.
19. Freeman G., Colston J., Zabalgoitia M., Chandrasekar B. Contractile depression and expression of proinflammatory cytokines and iNOS in viral myocarditis. American Journal of Physiology 1998, 274:H249-H258.
20. Frohlich A., Kisielow J., Schmitz I., Freigang S., Shamshiev A.T., Weber J., Marsland B.J., Oxenius A., Kopf M. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009, 324:1576-1580.
21. Guthrie M., Lodge P.A., Huber S.A. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes. Cellular Immunology 1984, 88:558-567.
22. Huber S. Host immune responses to coxsackievirus B3. Current Topics in Microbiology and Immunology 2008, 323:199-221.
23. Huber S., Cunningham M. Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. Journal of Immunology 1996, 156:3528-3534.
24. Huber S., Gauntt C. Antigenic Mimicry Between Self and Coxsackievirus Protein Leads to Both Humoral and Cellular Autoimmunity to Heart Proteins 2000, ASM Press.
25. Huber S., Lodge P. Coxsackievirus B3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. The American journal of pathology 1984, 116:21.
26. Huber S., Lodge P. Coxsackievirus B3 myocarditis: identification of different mechanisms in DBA/2 and Balb/c mice. American Journal of Pathology 1986, 122:284.
27. Huber S., Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. Journal of Virology 1994, 68:5126-5132.
28. Huber S., Lodge P., Herzum M., Estrin M., Olszewski J. The role of T lymphocytes in the pathogenesis of coxsackievirus B3 myocarditis. Cardiomyopathy Update 1: Pathogenesis of Myocarditis and Cardiomyopathy 1987, 9-21. University of Tokyo Press, Tokyo. C. Kawai, W. Abelmann, A. Matsumori (Eds.).
29. Huber S., Graveline D., Born W., O'Brien R. Cytokine production by Vgamma+ T cell subsets is an important factor determining CD4+ Th cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis. Journal of Virology 2001, 75:5860-5868.
30. Huber S.A., Sartini D., Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. Journal of Virology 2002, 76:10785-10790.
31. Kang B.S., Palma J.P., Lyman M.A., Dal Canto M., Kim B.S. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells. Virology 2005, 340:84-94.
32. Kaya Z., Dohmen K.M., Wang Y., Schlichting J., Afanasyeva M., Leuschner F., Rose N.R. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. Journal of Immunology 2002, 168:1552-1556.
33. Knowlton K.U., Jeon E.S., Berkley N., Wessely R., Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. Journal of Virology 1996, 70:7811-7818.
34. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.
35. Li Y., Bleakley M., Yee C. IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response. Journal of Immunology 2005, 175:2261-2269.
36. Liao L., Sindhwani j., Leinwand L., Diamond B., Factor S. Cardiac a-myosin heavy chains differ in their induction of myocarditis: identification of pathogenic epitopes. The Journal of Clinical Investigation 1993, 92:2877-2882.
37. Liao L., Sindhwani R., Rojkind M., Factor S., Leinwand L., Diamond B. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. The Journal of Experimental Medicine 1995, 187:1123-1131.
38. Linterman M.A., Beaton L., Yu D., Ramiscal R.R., Srivastava M., Hogan J.J., Verma N.K., Smyth M.J., Rigby R.J., Vinuesa C.G. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. The Journal of Experimental Medicine 2010, 207:353-363.
39. Lodge P., Herzum M., Olszewski J., Huber S. Coxsackievirus B3-myocarditis: acute and chronic forms of the disease caused by different immunopathogenic mechanisms. American Journal of Pathology 1987, 128:455-463.
40. Maisch B. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury. Springer Seminars in Immunopathology 1989, 11:369-396.
41. Maisch B., Bauer E., Cirsi M., Kocksiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Circulation 1993, 87(Suppl. IV):49-65.
42. McHeyzer-Williams L.J., Pelletier N., Mark L., Fazilleau N., McHeyzer-Williams M.G. Follicular helper T cells as cognate regulators of B cell immunity. Current Opinion in Immunology 2009, 21:266-273.
43. Novy P., Huang X., Leonard W.J., Yang Y. Intrinsic IL-21 signaling is critical for CD8 T cell survival and memory formation in response to vaccinia viral infection. Journal of Immunology 2011, 186:2729-2738.
44. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
45. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse H.C., Liu C., Schwartzberg P.L., Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
46. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S., Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J., Conklin D., Presnell S.R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C., Moore M., Grant F.J., Lofton-Day C., Gilbert T., Rayond F., Ching A., Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K., Holly R.D., Foster D. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
47. Pot C., Apetoh L., Awasthi A., Kuchroo V.K. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. Journal of Interferon and Cytokine Research 2010, 30:381-388.
48. Publicover J., Goodsell A., Nishimura S., Vilarinho S., Wang Z.E., Avanesyan L., Spolski R., Leonard W.J., Cooper S., Baron J.L. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. The Journal of Clinical Investigation 2010, 121:1154-1162.
49. Rose N.R. The adjuvant effect in infection and autoimmunity. Clinical Reviews in Allergy & Immunology 2008, 34:279-282.
50. Rueckert R. Picronaviruses 1996, Lippincott-Raven, Philadelphia, PA.
51. Sonderegger I., Kisielow J., Meier R., King C., Kopf M. IL-21 and IL-21R are not required for development of TH17 cells and autoimmunity in vivo. European Journal of Immunology 2008, 38:1833-1838.
52. Spolski R., Leonard W.J. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annual Review of Immunology 2008, 26:57-79.
53. Spolski R., Leonard W.J. IL-21 is an immune activator that also mediates suppression via IL-10. Critical Reviews in Immunology 2011, 30:559-570.
54. Spolski R., Kim H.P., Zhu W., Levy D.E., Leonard W.J. IL-21 mediates suppressive effects via its induction of IL-10. Journal of Immunology 2009, 182:2859-2867.
55. Suto A., Kashiwakuma D., Kagami S., Hirose K., Watanabe N., Yokote K., Saito Y., Nakayama T., Grusby M.J., Iwamoto I., Nakajima H. Development and characterization of IL-21-producing CD4+ T cells. The Journal of Experimental Medicine 2008, 205:1369-1379.
56. Van Houten N., Bouchard P., Moraska A., Huber S. Selection of an attenuated coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. Journal of Virology 1991, 65:1286-1290.
57. Williams L.D., Bansal A., Sabbaj S., Heath S.L., Song W., Tang J., Zajac A.J., Goepfert P.A. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. Journal of Virology 2011, 85:2316-2324.
58. Woodruff J., Woodruff J. Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. Journal of Immunology 1974, 113:1726-1734.
59. Yi J.S., Cox M.A., Zajac A.J. Interleukin-21: a multifunctional regulator of immunity to infections. Microbes and Infection 2010, 12:1111-1119.
60. Yi J.S., Ingram J.T., Zajac A.J. IL-21 deficiency influences CD8 T cell quality and recall responses following an acute viral infection. Journal of Immunology 2010, 185:4835-4845.
61. Zeng R., Spolski R., Finkelstein S.E., Oh S., Kovanen P.E., Hinrichs C.S., Pise-Masison C.A., Radonovich M.F., Brady J.N., Restifo N.P., Berzofsky J.A., Leonard W.J. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. The Journal of Experimental Medicine 2005, 201:139-148.
62. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 2007, 8:967-974.
63. Zotos D., Coquet J.M., Zhang Y., Light A., D'Costa K., Kallies A., Corcoran L., Godfrey D.I., Toellner K.M., Smyth M.J., Nutt S.L., Tarlinton D.M. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. The Journal of Experimental Medicine 2010, 207:365-378.